🔆 Beacon

← Search all trials on Beacon

Outside the Cage (OTC) Robotic Esophagectomy

Opening soon Phase 1 NCT06735638

Run by Centre hospitalier de l'Université de Montréal (CHUM) · for 18 and older · All sexes

What this study is about

The goal of this clinical trial is to evaluate the feasibility and safety of a novel non-intercostal robotic approach for minimally invasive esophagectomy (OTC MIE) in the treatment of esophageal cancer. This study aims to determine whether OTC MIE reduces the risk of acute and chronic chest pain compared to traditional minimally invasive esophagectomy (MIE) and improves postoperative outcomes for patients. Participants will undergo either the OTC MIE procedure or a traditional MIE approach as part of their treatment for esophageal cancer. Postoperative outcomes, including chest pain and recovery metrics, will be closely monitored. Follow-up assessments will be conducted to evaluate the long-term safety and effectiveness of the novel approach. The investigators aim to recruit 31 patients.

Who can join (things the study team will check)

🚫 You may not be able to join if…

Where this trial is running

Who to contact

Moishe Liberman · 514-890-8000 · moishe.liberman@umontreal.ca

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT06735638.

Open the interactive checklist for this trial →

Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.

Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.